RecallDepth
Class II Terminated

Excedrin Migraine (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-count tablets packaged in pouches, Distributed by Novartis Consumer Health, Inc., Parsippany, NJ, NDC 0067 203 702 Foreign packaging: b) Excedrin Migrana (Acetaminophen 250 mg, Aspirin 250 mg and 65 mg Caffeine) 2-ct pouches. The foreign packaging do not have NDC numbers

Company
Novartis Consumer Health
Recall Initiated
June 6, 2013
Posted
August 14, 2013
Recall Number
D-844-2013
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
10,624,000 pouches
Firm Location
Lincoln, NE, United States

Reason for Recall

Defective container: products are packaged in pouches which may not have been fully sealed

Distribution

Nationwide, Puerto Rico, Brazil and Panama

Lot / Code Info

Lot # a) 10116809, Exp 5/13 Foreign: Lot #s b) 10115644 Exp 5/13; 10118226 Exp 5/13; 10118227 Exp 6/13; 10118228 Exp 6/13; 10121956 Exp 8/13 and 10121957 Exp 8/13

More recalls by Novartis Consumer Health

View all recalls by this company →

Other recent Class II Drug recalls